<?xml version="1.0" encoding="UTF-8"?>
<jcr:root xmlns:jcr="http://www.jcp.org/jcr/1.0" xmlns:nt="http://www.jcp.org/jcr/nt/1.0" xmlns:mix="http://www.jcp.org/jcr/mix/1.0" xmlns:cq="http://www.day.com/jcr/cq/1.0" xmlns:sling="http://sling.apache.org/jcr/sling/1.0"
    jcr:primaryType="cq:Page">
    <jcr:content
        cq:lastModified="{Date}2024-02-08T13:18:28.176Z"
        cq:lastModifiedBy="menarini-user"
        cq:template="/conf/menarini-berlinchemie/settings/wcm/templates/menarini---news-year"
        jcr:isCheckedOut="{Boolean}true"
        jcr:mixinTypes="[mix:versionable]"
        jcr:primaryType="cq:PageContent"
        jcr:title="2023"
        jcr:uuid="f844f036-7cc6-4724-8cb6-279d83eb6939"
        sling:resourceType="menarinimaster/components/page">
        <root
            jcr:primaryType="nt:unstructured"
            sling:resourceType="menarinimaster/components/container"
            layout="responsiveGrid">
            <container
                jcr:primaryType="nt:unstructured"
                sling:resourceType="menarinimaster/components/container"
                layout="responsiveGrid">
                <internalheader
                    jcr:lastModified="{Date}2022-05-27T16:15:23.398+02:00"
                    jcr:lastModifiedBy="admin"
                    jcr:primaryType="nt:unstructured"
                    sling:resourceType="menarinimaster/components/internalheader"/>
                <section
                    jcr:lastModified="{Date}2023-05-23T15:04:29.514Z"
                    jcr:lastModifiedBy="a.messori@adiacent.com"
                    jcr:primaryType="nt:unstructured"
                    sling:resourceType="menarinimaster/components/section">
                    <wrapper
                        jcr:lastModified="{Date}2023-05-23T15:05:56.279Z"
                        jcr:lastModifiedBy="a.messori@adiacent.com"
                        jcr:primaryType="nt:unstructured"
                        sling:resourceType="menarinimaster/components/wrapper">
                        <breadcrumb
                            jcr:lastModified="{Date}2022-05-27T16:15:51.228+02:00"
                            jcr:lastModifiedBy="admin"
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/breadcrumb"/>
                    </wrapper>
                </section>
                <section_1473771530
                    jcr:lastModified="{Date}2023-05-23T15:06:16.651Z"
                    jcr:lastModifiedBy="a.messori@adiacent.com"
                    jcr:primaryType="nt:unstructured"
                    sling:resourceType="menarinimaster/components/section">
                    <wrapper
                        jcr:lastModified="{Date}2023-10-18T15:52:37.825+02:00"
                        jcr:lastModifiedBy="admin"
                        jcr:primaryType="nt:unstructured"
                        sling:resourceType="menarinimaster/components/wrapper"
                        layout="responsiveGrid">
                        <container
                            jcr:created="{Date}2023-10-18T15:52:26.399+02:00"
                            jcr:createdBy="admin"
                            jcr:lastModified="{Date}2023-10-18T15:52:26.399+02:00"
                            jcr:lastModifiedBy="admin"
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/container">
                            <title
                                cq:styleIds="[1653552493699]"
                                jcr:lastModified="{Date}2022-07-27T15:16:55.510+02:00"
                                jcr:lastModifiedBy="admin"
                                jcr:primaryType="nt:unstructured"
                                sling:resourceType="menarinimaster/components/title"
                                linkTarget="_self"
                                type="h2"/>
                            <news_list
                                jcr:created="{Date}2023-10-18T15:53:12.823+02:00"
                                jcr:createdBy="admin"
                                jcr:lastModified="{Date}2023-10-18T15:53:12.823+02:00"
                                jcr:lastModifiedBy="admin"
                                jcr:primaryType="nt:unstructured"
                                sling:resourceType="menarinimaster/components/news_list"/>
                            <cq:responsive jcr:primaryType="nt:unstructured">
                                <default
                                    jcr:primaryType="nt:unstructured"
                                    offset="0"
                                    width="9"/>
                            </cq:responsive>
                        </container>
                        <container_1174168567
                            jcr:created="{Date}2023-10-18T15:53:22.255+02:00"
                            jcr:createdBy="admin"
                            jcr:lastModified="{Date}2023-10-18T15:53:22.255+02:00"
                            jcr:lastModifiedBy="admin"
                            jcr:primaryType="nt:unstructured"
                            sling:resourceType="menarinimaster/components/container">
                            <title
                                cq:styleIds="[1653552493699]"
                                jcr:created="{Date}2023-10-18T15:53:49.171+02:00"
                                jcr:createdBy="admin"
                                jcr:lastModified="{Date}2023-10-18T16:09:03.757+02:00"
                                jcr:lastModifiedBy="admin"
                                jcr:primaryType="nt:unstructured"
                                jcr:title="News Archive"
                                sling:resourceType="menarinimaster/components/title"
                                linkTarget="_self"
                                type="h2"/>
                            <news_archive
                                jcr:created="{Date}2023-10-18T15:54:03.098+02:00"
                                jcr:createdBy="admin"
                                jcr:lastModified="{Date}2023-10-18T15:54:03.098+02:00"
                                jcr:lastModifiedBy="admin"
                                jcr:primaryType="nt:unstructured"
                                sling:resourceType="menarinimaster/components/news-archive"/>
                            <button
                                cq:styleIds="[1653579684271,1653579730618]"
                                jcr:created="{Date}2023-10-18T15:54:10.140+02:00"
                                jcr:createdBy="admin"
                                jcr:lastModified="{Date}2023-10-18T16:16:09.622+02:00"
                                jcr:lastModifiedBy="admin"
                                jcr:primaryType="nt:unstructured"
                                jcr:title="GO TO NEWS ARCHIVE"
                                sling:resourceType="menarinimaster/components/button"
                                linkTarget="_self"/>
                            <cq:responsive jcr:primaryType="nt:unstructured">
                                <default
                                    jcr:primaryType="nt:unstructured"
                                    offset="0"
                                    width="3"/>
                            </cq:responsive>
                        </container_1174168567>
                    </wrapper>
                </section_1473771530>
            </container>
        </root>
    </jcr:content>
    <menarini-group-presented-initial-safety-and-efficacy-data-from-phase-1b-2-elevate-and-electra-combination-studies-of-orserdu-elacestrant-in-patients-with-er---her2--metastatic-breast-cancer-mbc/>
    <menarini-group-presents-new-progression-free-survival-data-from-emerald-clinical-study-of-orserdu-elacestrant-in-clinically-relevant-subgroups-of-patients-with-er---her2--metastatic-breast-cancer/>
    <menarini-group-announces-new-data-on-orserdu-elacestrant-at-the-2023-san-antonio-breast-cancer-symposium-and-on-elzonris-tagraxofusp-erzs-at-the-65th-american-society-of-hematology/>
    <menarini-group-and-sciclone-pharmaceuticals-announce-exclusive-sub-licensing-collaboration-to-develop-and-commercialize-orserdu-elacestrant-in-china-to-address-advanced-or-metastatic-breast-cancer/>
    <european-organisation-for-research-and-treatment-of-cancer-_x0026_-the-menarini-group-launch-new-clinical-trial-in-early-stage-breast-cancer/>
    <the-2023-season-gets-underway-for-the--volpi-rosse-menarini-wheelchair-basketball-team/>
    <european-commission-approves-menarini-group-s-orserdu-sup---sup--elacestrant-for-the-treatment-of-patients-with-er---her2--locally-advanced-or-metastatic-breast-cancer-with-an-activating-esr1-mutation/>
    <the-menarini-group-announces-elzonris-tagraxofusp-designated-as-an-orphan-drug-for-bpdcn-by-japanese-ministry-of-health--labor-and-welfare/>
    <menarini-group-receives-positive-chmp-opinion-recommending-ec-approval-of-orserdu-elacestrant-for-the-treatment-of-patients-with-er---her2--locally-advanced-or-metastatic-breast-cancer/>
    <fair-play-menarini-international-awards--the-champions-of-fair-play-cast-their-spell-on-the-audience-in-fiesole/>
    <fair-play-menarini-international-awards---excitement-is-building-for-the-awards-ceremony-after-the---the-champions-tell-their-stories-/>
    <great-news-at-the-fair-play-menarini-international-awards---tennis-player-francesca-schiavone-among-the-winners-of-the-2023-edition/>
    <fair-play-menarini-international-awards--the-2023-edition-starts-with-the-talk-show--the-champions-tell-their-stories--in-piazza-della-signoria--florence/>
    <fair-play-menarini-international-awards--young-swimmer-gianluca-gensini-wins-the---fiamme-gialle--special--studio-and-sport--award/>
    <fair-play-menarini-international-awards-announces-the-winners-of-the-xxvii-edition-at-coni/>
    <menarini-group-shares-nexpovio-selinexor-subgroup-data-from-boston-trial-at-the-european-hematology-association-congress--highlighting-clinical-potential-in-relapsed-refractory-multiple-myeloma/>
    <menarini-group-shares-new-analysis-from-emerald-clinical-study-of-orserdu-sup---sup--elacestrant-in-metastatic-breast-cancer-at-asco-2023/>
    <botticelli--the-inquietude-and-the-beauty/>
    <menarini-group-announces-new-data-on-elacestrant-at-2023-esmo-breast-cancer-congress-and-2023-asco-annual-meeting/>
    <birth-rate-emergency--younger-generations-say---it-s-not-just-an-issue-of-economic-stability-/>
    <the-doors-of-europe-open-wide-for-the-volpi-rosse-menarini/>
    <menarini-announces-an-exclusive-distribution-agreement-for-boditech-s-afias-10-system/>
    <the-dates-of-the-xxvii-edition-of-the-international-fair-play-menarini-awards/>
    <neoplasia-a-cellule-dendritiche-plasmacitoidi-blastiche--aifa-approva-tagraxofusp-prima-e-unica-terapia-contro-tumore-del-sangue-raro-e-aggressivo/>
    <karyopharm-and-menarini-group-receive-full-marketing-authorization-from-the-uk-medicines-_x0026_-healthcare-products-regulatory-agency-for-nexpovio-sup---sup--selinexor/>
    <menarini-group-are-with-the-turkish-and-syrian-populations/>
    <stemline-therapeutics--a-subsidiary-of-menarini-group--receives-u-s--fda-approval-for-orserdu--elacestrant-as-the-first-and-only-treatment-specifically-indicated-for-patients-with-esr1-mutations/>
</jcr:root>
